Home
TISSIUM S.A.

TISSIUM S.A. Market Share Analysis for March 2026

TISSIUM is headquartered in Paris, France with a manufacturing site near Lille, France and an office in Boston, USA.

Industry: N/A

Domaintissium.com

Year Founded2013

Employees51 - 200

Annual Revenue$25M - $50M

TISSIUM S.A.

TISSIUM S.A. (including company regionals)

tissium.com

See more website traffic and engagement information

TISSIUM S.A. Revenue up to March 2026 is 25M - 50M

revenue generated by TISSIUM S.A. top domains

TISSIUM S.A. top domains revenue over 3 years

Revenue for TISSIUM S.A. top domains

tissium.com25M - 50M

See more with Sales Intelligence

Total visits to TISSIUM S.A.'s top domains

Understand TISSIUM S.A. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

tissium.com5.3K

See more with Sales Intelligence

Avg. visit duration in TISSIUM S.A.'s top domains

Analyze TISSIUM S.A. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

tissium.com00:00:07

See more with Sales Intelligence

Avg. pageviews on TISSIUM S.A.'s top domains

See how TISSIUM S.A. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

tissium.com1.29

See more with Sales Intelligence

TISSIUM S.A. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by TISSIUM S.A.

These are the website technologies, by industry, used by TISSIUM S.A. top domains

Conversion & Analytics (4)

Google Analytics

Marketing (4)

Google Marketing Platform

Advertising (3)

DoubleClick

Widget (3)

Twemoji

More Technologies

8

See all

News & Signals from TISSIUM S.A.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTissium SA is developing TISSIUM platform.TISSIUM(R) continues to actively explore the expansion of the TISSIUM(R) platform across other applications, including nerve repair.

NewsTissium SA attended event IFSSH Congress on Mar 27th '25.Paris, France, Cambridge, USA, April 2nd, 2025 - TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, is proud to unveil clinical data which were presented at the IFSSH Congress in Washington, D.C. on March 27, 2025, demonstrating the potential of its COAPTIUM(R) CONNECT System, an innovative atraumatic sutureless solution for peripheral nerve repair.

NewsTissium SA is developing portfolio of products that leverage proprietary family of fully biosynthetic, biomorphic, and programmable polymers.TISSIUM is developing a portfolio of products that leverage its proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are the foundation of the company's technology platform.